Table 1.
IC50 values for DATS and DOX treated against MCF7, MDA-MB-231 and A549, LoVo, and HA22T cancer cells for the indicated times
| IC50 (µM) | SDTV | 95% CI | ||
|---|---|---|---|---|
| Cell/Treatment | Mean | (±) | Lower | Upper |
| MCF7 DOX 24 h | 1.63 | 0.15 | 1.3 | 2.0 |
| MCF7 DOX 48 h | 0.9 | 0.07 | 0.7 | 1.0 |
| MCF7 DATS 24h | 94 | 4.0 | 84 | 104 |
| MCF7 DATS 48 h | 58 | 2.5 | 52 | 65 |
| MDA-MB-231 DOX 24 h | 2.1 | 0.20 | 1.6 | 2.6 |
| MDA-MB-231 DOX 48 h | 1.3 | 0.25 | 0.71 | 1.96 |
| MDA-MB-231 DATS 24 h | 84 | 3.1 | 76 | 91 |
| MDA-MB-231 DATS 48 h | 49 | 1.5 | 46 | 53 |
| A549 DATS 24h | 78 | 1.5 | 74 | 81 |
| LoVo DATS 24h | 72 | 1.5 | 69 | 76 |
| HA22T DATS 24h | 103 | 2 | 98 | 108 |